IRCT201103243930N4已完成2 期
Acetylcysteine Augmentation in Treatment of Refractory Obsessive-Compulsive Disorder, a double blind randomized placebo controlled clinical trial
Vice chancellor for research, Shiraz University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 10 years 至 20 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria are: DSM-IV diagnosis of OCD; symptoms of at least 1 year duration, moderate to severe OCD symptoms (Y-BOCS > 16), and failure of an adequate trial of an SSRI.
- •Exclusion Criteria are: primary diagnosis of a psychotic disorder, active substance abuse or dependence, unstable medical condition, prior exposure to N-Acetylcysteine, pregnancy, breastfeeding, or intent to become pregnant during study, evidence of active liver disease, seizure disorder, and active suicidal ideation.
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Adjuvant N Acetylcysteine for Post Traumatuic Stress DisorderACTRN12618001784202Austin Health105
尚未招募
Unknown
AC for treatment of Obsessive-Compulsive DisorderObsessive-compulsive disorderObsessive-compulsive disorder.IRCT20170123032145N7Iran University of Medical Sciences44
招募中
2 期
Effect of N-acetylcysteine as adjunct therapy versus placebo on clinical outcomes and serum levels of oxidative stress biomarkers in patients with systolic heart failureIRCT20120215009014N333Hamedan University of Medical Sciences80
尚未招募
3 期
Acetyl Cysteine in the management of Zinc Phosphide PoisoningCTRI/2024/03/064278J.L.N Medical College and Hospital
已完成
1 期
A randomized double blind, placebo-controlled clinical trial with oral n-acetylcysteine in systemic sclerosis patients and assessment of skin blood flow of the hands with laser Doppler perfusion imagingmicrocirculationfingertip blood flowInflammatory and Immune System - Connective tissue diseasessystemic sclerosisACTRN12610000114044Foundation for the support for research in the state of Sao Paulo40